Market cap means nothing at this point in time. Totally disagree. Main thing right now is to concentrate on getting the ART through human clinicals. Once that is done then to see how the ART is accepted in the market place. Once revenues start to ramp the market cap will start to take care of itself.
Elite can either go about taking care of shares outstanding by a reverse split or by a buy back and retirement of shares.
Market cap is the least of the worries as far as I am concerned right now. And NO! I have no idea of what you are driving at except to say that it seems like some here want to make their money NOW. This is a long term play. Possibly years.
Potential hundreds of millions in revenue versus what the revenue is now will surely increase the PE ratio to a nice number. I do not care what they have right now in shares outstanding. I get that. Later I am sure this "problem" will be addressed and will no longer be a road block for better share price value.
If they cut the number of shares in half or by a third I will be fine. The days of 10 million share outstanding are long gone.
Market Data 
Markets 
AI
